Drug Name: Daybue
Indications: To treat Rett syndrome
Active Ingredient: Trofinetide
Company: Acadia Pharmaceuticals Inc
Approval Date: 3/10/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217026s000lbl.pdf
Drug Name: Daybue
Indications: To treat Rett syndrome
Active Ingredient: Trofinetide
Company: Acadia Pharmaceuticals Inc
Approval Date: 3/10/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217026s000lbl.pdf